C-terminal truncated dystrophin identified in skeletal muscle of an asymptomatic boy with a novel nonsense mutation of the dystrophin gene

Pediatr Res. 2004 Nov;56(5):739-43. doi: 10.1203/01.PDR.0000142734.46609.43. Epub 2004 Sep 15.

Abstract

Mutations that cause premature stop codons in the dystrophin gene lead to a complete loss of dystrophin from skeletal muscle, resulting in severe Duchenne muscular dystrophy. Here, a C-terminally truncated dystrophin resulting from a novel nonsense mutation is shown for the first time to be localized to the muscle plasma membrane. An asymptomatic 8-y-old boy was examined for dystrophin in skeletal muscle because of high serum creatine kinase activity. Remarkably, no dystrophin labeling was seen with an MAb against the C-terminal domain, suggesting the presence of an early stop codon in the dystrophin gene. Labeling with an antibody specific to the N-terminal domain, however, revealed weak, patchy, and discontinuous staining, suggesting limited production of a truncated form of the protein. Molecular analysis revealed a novel nonsense mutation (Q3625X) as a result of a single nucleotide change in the patient's genomic DNA (C10873T), leaving 1.6% of dystrophin gene product unsynthesized at the C terminus. Dystrophin mRNA analysis did not show rescue of the nonsense mutation as a result of exon-skipping by an alternative splicing mechanism. This is the first report of an asymptomatic dystrophinopathy with a nonsense mutation in the dystrophin gene.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • Codon, Nonsense*
  • Creatine Kinase / blood
  • Dystrophin / chemistry
  • Dystrophin / genetics*
  • Humans
  • Male
  • Muscle, Skeletal / physiology*
  • Muscular Dystrophy, Duchenne / blood
  • Muscular Dystrophy, Duchenne / genetics*
  • Phenotype
  • Protein Structure, Tertiary

Substances

  • Codon, Nonsense
  • Dystrophin
  • Creatine Kinase